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Background: Bone marrow (BM) derived stem cells secrete multiple growth factors and 
have been shown to differentiate to cardiomyocytes and endothelial cells in mice. This 
study evaluated the effect of trans-epicardial BM cell transplantation in a porcine non- 
rep&used myocardial infarction model. 
Methods: In 14 domestic pigs, myocardial infarction was created by occludmg the first 
diagonal artery with coils. Twenty-eight days later, Iliac crest BM cells were aspirated, fil- 
tered, labeled with bromodeoxyuridine (BrdU) and cultured for 46 hrs Injections of 0.2 ml 
(-1.5 million cells/ml) (BM. n=l 1 pigs and saline, n=3 pigs) were evenly distributed lcm 
apart in the scar (6 injections) and around the scar (6 InJections). Animals were sacrificed 
at 4 (n=3), 14 (n=4) and 28 days (n=7) for histology and immunohistochsmistry analysis. 
Tram-epicardial echocardiography was performed at the time of injection and at sacrifice 
to assess reglonal contractility. 
Results Positive BrdU cells were identified in infarcted areas at 4, 14 and 26 days of BM 
transplanted animals. Muscle cells @-actink positive cells) in the scar tissue were 
21.1+15.7 /mm2 in the BM group and 13.6k2.4 /mm2 an the saline group at 26 days 
(p=O.O7). At 26 days the number of endothellal cells (factor VIII positive cells) was 
greater in the BM group than in the saline group (19.5&.9 vs. 6.9i15.1 cells/m& 
p=O.O7). Capillaries >b@m at 28 days were 10.95*3.02 /mm2 in the BM group and 
4.6+0.4 /mm2 in the saline group (p=O.Ol). Wall Motion Score Index was 2.0*0.1 at base- 
line and 2.3+0.12 at 28 days in the BM group (p=O.lS) and 2.OkO.l in the saline group at 
26 days, (p=O.40 vs BM). 
Conclusion: Bone marrow cell engraftment is feasible with viable transplanted cells at 
28 days within scar tissue of non-reperfused myocardial Infarction. Angiogenesis was 
improved after BM inlectlon. However, higher muscle cell area and vascular density in 
the scar were not correlated with improvement of left ventricular function at 26 days. 
1178-140 Caldesmon Regulates Apoptosis and Cell Cycle 
Progression in Capillary Endothelial Cells and Inhibits 
Angiogenesis In Vitro 
Yasushl Numaauchl, Sui Huang, Donald E. Ingber, Children’s Hospital/Harvard Medical 
School, Boston, MA 
Capillary endothelial (CE) cells can be switched between growth and apoptosis by modu- 
lating their shape and cytoskeleton (CSK) using micropatterned adhesive islands (SCI- 
ence 1997; 276:1425-1426). To further examine how the CSK contributes to this 
switching mechanism, we used an adenoviral vector carrying caldesmon, which inhibits 
CSK tension generation antagonizing Rho activity and disassembles acto-myosin fila- 
ments when overexpressed. Associated changes in cell shape and CSK organization 
were visualized tn living cells by expressmg GFP-caldesmon under tight control of a Tet- 
off system. Increase in cellular GFP-caldesmon resulted in progressive loss of actin 
stress fibers, disassembly of focal adhesions and cell retraction; the most highly 
retracted cells covered about one-third the project cell area of controls. The apoptotic 
Index measured by quantitating TUNEL stammg increased in parallel as GFP-caldesmon 
levels were increased and cell retraction was promoted. The smallest cells exhiblted lev- 
els of apoptosis similar to that observed during anoikis in fully detached cells (42 vs. 55% 
TUNEL staining. respectively). Conversely, cell cycle progression into S phase (monl- 
tored by nuclear incorporation of BrdU at 24 hr) decreased from 35 to 9% as cells were 
progressively rounded up under similar conditions. In chicken aollic ring assay, GFP- 
caldesman transfectlon inhibited vascular sprouting up to 60% if compared with those of 
GFP alone or control (5.2mm vs. 10.5mm vs. 12.lmm diameter of sprouting area, 
respectively). These data confirm that the CSK mediates the mechanism by which extra- 
cellular matrix-dependent changes in cell shape influence CE cell growth and apoptosis 
during angiogenesis. The adenoviral vectors encoding GFP-caldesmon under Tet-off 
control also may prove useful in future studies analyzing the role of CSK tension and 
structure during control of capillary development in angiogenesis. 
1178-141 Can Vascular Endothelial Growth Factor Improve Blood 
Flow in Diabetes? 
Ariel Roauln, Samy Nltecki, lrlt Rubinsteln, Edmond Sabo, Zaid A. Abassl, Nina S. Levy, 
Aaron Hoffman, Andrew P. Levy, Technion IIT, Haifa, Israel, Rambam Medical Center. 
Halfa, Israel 
Diabetes Mellitus (DM) is associated with increased cardiovascular morbidity and mortal- 
ity. Collaterals can protect from ischemia. ConsIderable debate exists concerning the 
size and extent of the collateral circulation in DM. Our aim was to evaluate the usefulness 
of continuous oerimuscular infiltration of naked-DNA encodina VEGF. to auament collat- 
era1 formation and tissue perfusion in a DM mouse unilateral ischemic hindlimb model. 
Methods: DM was induced with StreDtozotocin (80 ma/ka). An osmotic DU~D with saline 
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or 500microgram VEGF was implanted intra-abdomrnaly with an outlet-tube fenestrated 
and tunneled Into the muscle. Ischemiclnormal limb blood flow was measured using a 
laser Doppler blood flowmeter once a week, tissues were analyzed for smooth muscle 
actin and factor-6. DM mice were compared to normal mice. 
Results: In normal mice, a faster restoratIon of blood flow was observed in the VEGF 
treated, however in the DM mice, there was no difference in the rate of flow restoration 
between the VEGF-treated or placebo-treated arm (graph). The blood flow was almost 
complete for the normal mice but reached a ratio of 0.6-0.9 for both DM arms and for nor- 
mal placebo. The blood vessel density was higher for the both DM arms compared to the 
normal mice. 
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Conclusion: Our results demonstrate the rapid and successful restoration of blood flow 
using naked-DNA encoding VEGF in a normal mice but lack of benefit of VEGF adminis- 
tration in DM mice. This may have major implication on angiogenic treatment in patients 
with DM. 
1178-142 IL-6 Is Produced by Splenocytes Derived From CMV- 
Infected Mice in Response to CMV Antigens, and 
Induces MCP-1 Production by Endothelial Cells: A New 
Mechanistic Paradigm for Infection-Induced 
Atherogenesis 
David Rot1 Jianhui Zhu, Mary Susan Burnett, Yi Fu Zhou. Alexandra Zalles-Ganley, 
Stephen E. Epstein, Washington Hospital Center, Washington, DC 
Background: Atherosclerosis is an inflammatory disease. One of the candidate inflamma- 
tory triggers is infection. To further characterize the Interaction between infection, cytok- 
me induction, and atherosclerosis, we tested the hypothesis that cytomegalovirus (CMV) 
infection induces the pro-inflammatory cytokine interleukin-6 (IL-6), which in turn induces 
“pro-atherosclerotic” changes in vascular endothelial cells (ECs). 
Methods: ELISA was used to determine the levels of monocyte chemoattractant protein- 
1 (MCP-1) in the supernatant of mouse and human ECs incubated with IL-6, and IL-6 lev- 
els I” supematants of splenocytes, derived from CMV infected and unmfected mice, stim- 
ulated with mouse CMV antigens. 
Results: IL-6 Induced, in a dose response fashion, MCP-1 expression in human ECs: 0, 
2, 10, and 50 pg/ml IL-6 increased MCP-1 levels in EC conditioned medium from 
1120+65, to 1148+105. 1395i40, and 2119*130 pg/ml, respectively, (P trend < 0.001). 
IL-6 also induced MCP-1 expression in mouse ECs (p<O.O02). Importantly, IL-6 concen- 
tration in the supernatants of splenocyies stimulated with CMV antigens rose from unde- 
tectable levels in uninfected mice to14.925 pglml in the infected mice (P<O.O4). 
Conclusions: These results suggest a previously unrecognized, but potentially important 
mechanism whereby CMV, and other pathogens, contribute to atherogenesls: T-lympho- 
cytes, clonally expanded in response to antigens presented by CMV infection, home to 
sites of vascular injury and locally release IL-6 when presented with either pathogen anti- 
gens that may be present in the plaque, or when they cross-react with host peptides 
homologous to the relevant pathogen antlgens; IL-6 then triggers ECs to release MCP-1, 
which recruits more monocytes and T-cells into the vessel wall and thereby exacerbates 
local inflammation, and thus atherogenesis. 
1178-143 Angiogenesis Induced by Human Hepatocyte Growth 
Factor Gene Without Nitric Oxide Synthesis in a Rat 
lschemic Hindlimb Model 
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Medical School, Suita, Japan 
Background:Vascular endothelial growth factor has been reported that it has the effect 
of angiogenesis through the nitric oxide (NO). Hepatocyte growth factor (HGF) has also 
been reported to have the effect of anglogenesis. However, it has not been reported 
whether HGF induces anglogenesis through the NO. In this study, we examined the fea- 
sibility of gene therapy using the HGF gene to treat peripheral arierlal disease model rat 
in chronically inhibition of NO synthesis. 
Methods: L-NAME (NO synthesis inhibitor) was obtained by drinking water (Img/ml) 
from before resection of left femoral artery throughout this expenment. Sprague-Dawley 
rats were divided into three groups, which were transfected Human HGF naked plasmid 
DNA vector (5OOflg) or control vector (5O@g) with L-NAME administration, and control 
vector without L-NAME administration. The naked plasmid was transfected Into an 
ischemtc hindlimb by intramuscular injection at 1 week after resection. At 4 weeks after 
transfection, angiogenesis were assessed by angiography and tissue capillary density. 
Results:At 4 weeks after transfection. blood pressure was significantly increased in rats 
administrated with L-NAME. but HGF transfection by intramuscular Injection was not 
effect on blood pressure. The human HGF vector transfected rats administrated with L- 
NAME was resulted in significant increase in peripheral blood flow assessed by angiog- 
raphy compared with control vector administrated with L-NAME. Consistent with the 
increase in blood flow, a significant increase in tissue capillary number could be detected 
